Myriad Genetics Inc
F:MYD
Myriad Genetics Inc
F:MYD
Price:
5.868
EUR
5.81%
Market Closed
Market Cap:
€531.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
Alexander's Inc
F:AXE
|
US |
|
C
|
China Pacific Insurance Group Co Ltd
XMUN:75C
|
CN |
|
M
|
Mosaic Co
XMUN:02M
|
US |
|
A
|
AGCO Corp
F:AGJ
|
US |
|
Logitech international SA
F:LTEC
|
CH |
|
Grupo Aeroportuario del Sureste SAB de CV
F:AED
|
MX |
|
Pollard Banknote Ltd
F:67L
|
CA |
|
T
|
T&R Biofab Co Ltd
KOSDAQ:246710
|
KR |
|
S
|
Sumitomo Realty & Development Co Ltd
F:RL2
|
JP |
|
M
|
Mosaic Co
F:02M
|
US |
|
Grupo Aeroportuario del Sureste SAB de CV
F:AEDA
|
MX |
Intrinsic Value
Not Available for MYD
There is not enough data to reliably calculate the intrinsic value for Myriad Genetics Inc.
Do our valuations actually work? See backtest results .
Alternatives to MYD
Fundamental Analysis
What Myriad Genetics Does
Myriad Genetics makes genetic tests that help doctors understand a patient’s risk for certain diseases and choose treatment more precisely. Its core products are laboratory tests in areas such as hereditary cancer, women’s health, and some pharmacogenomic tests that look at how a person may respond to a medicine. The company sells these tests through physicians, hospitals, and health systems, and it gets paid when the tests are ordered and processed.
- Headquarters
- United States of America US
- Employees
- 2 700
- IPO date
- Oct 6, 1995
Financials
Revenue & Expenses Breakdown
Myriad Genetics Inc
Myriad Genetics Inc
Efficiency
Earnings Waterfall
Myriad Genetics Inc
Myriad Genetics Inc
